In vitro activities of novel 4-HPR derivatives on a panel of rhabdoid and other tumor cell lines

BACKGROUND: Rhabdoid tumors (RTs) are aggressive pediatric malignancies with poor prognosis. N-(4-hydroxy phenyl) retinamide (4-HPR or fenretinide) is a potential chemotherapeutic for RTs with activity correlated to its ability to down-modulate Cyclin D1. Previously, we synthesized novel halogen-sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Melissa E, Das, Bhaskar C, Kalpana, Ganjam V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204277/
https://www.ncbi.nlm.nih.gov/pubmed/21951911
http://dx.doi.org/10.1186/1475-2867-11-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204277/
https://www.ncbi.nlm.nih.gov/pubmed/21951911
http://dx.doi.org/10.1186/1475-2867-11-34

Ejemplares similares